首页> 外文期刊>World Journal of Gastroenterology >Technical advances in external radiotherapy for hepatocellular carcinoma
【24h】

Technical advances in external radiotherapy for hepatocellular carcinoma

机译:肝癌体外放疗的技术进展

获取原文
           

摘要

Radiotherapy techniques have substantially improved in the last two decades. After the introduction of 3-dimensional conformal radiotherapy, radiotherapy has been increasingly used for the treatment of hepatocellular carcinoma (HCC). Currently, more advanced techniques, including intensity-modulated radiotherapy (IMRT), stereotactic ablative body radiotherapy (SABR), and charged particle therapy, are used for the treatment of HCC. IMRT can escalate the tumor dose while sparing the normal tissue even though the tumor is large or located near critical organs. SABR can deliver a very high radiation dose to small HCCs in a few fractions, leading to high local control rates of 84%-100%. Various advanced imaging modalities are used for radiotherapy planning and delivery to improve the precision of radiotherapy. These advanced techniques enable the delivery of high dose radiotherapy for early to advanced HCCs without increasing the radiation-induced toxicities. However, as there have been no effective tools for the prediction of the response to radiotherapy or recurrences within or outside the radiation field, future studies should focus on selecting the patients who will benefit from radiotherapy.
机译:在过去的二十年中,放射治疗技术得到了极大的改善。在引入三维保形放疗后,放疗已越来越多地用于治疗肝细胞癌(HCC)。当前,更先进的技术,包括强度调制放射疗法(IMRT),立体定向消融身体放射疗法(SABR)和带电粒子疗法,被用于治疗HCC。即使肿瘤很大或位于关键器官附近,IMRT仍可在扩大正常组织的同时增加肿瘤剂量。 SABR可以在很小的几分率下向小的HCC传递非常高的辐射剂量,从而导致84%-100%的高局部控制率。各种先进的成像方式可用于放射治疗的计划和交付,以提高放射治疗的精度。这些先进的技术使早期至晚期HCC可以接受大剂量放射治疗,而不会增加放射线诱发的毒性。但是,由于尚无有效的工具来预测放疗内或外对放疗或复发的反应,因此未来的研究应集中在选择将从放疗中受益的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号